Brainomix partners with Medtronic to enhance stroke care

New collaboration aims to integrate AI solutions for treatment

Brainomix, a leader in stroke AI imaging software, has announced a strategic partnership with Medtronic Neurovascular to improve stroke care across Western Europe.

The collaboration seeks to integrate advanced AI solutions into clinical practice, expanding access to life-saving treatments and improving patient outcomes.

Brainomix’s 360 Stroke platform uses AI algorithms to provide real-time interpretation of brain scans, aiding treatment and transfer decisions for stroke patients. This technology was studied in the largest real-world evaluation of stroke AI, involving over 450,000 patients across England over five years, showing a doubling of thrombectomy rates in Brainomix sites, and a 37% increase compared to non-evaluation sites.

The partnership combines Brainomix’s AI-powered imaging technology with Medtronic’s expertise in neurovascular treatments. It supports faster, more accurate diagnoses, enabling healthcare professionals to make better-informed decisions and deliver life-saving interventions efficiently.

Dr Michalis Papadakis, CEO and Co-Founder of Brainomix, highlighted the shared vision of both companies: “This partnership with Medtronic is a natural fit, with the leading neurovascular device provider joining forces with the leading stroke AI imaging partner, both aligned around a mutual commitment towards improving stroke care for all patients.”

Dr Alex Solich, Senior Consultant for Neurointervention at Karolinska University Hospital & Örebro Hospital, emphasised the impact on patient outcomes: “As a stroke physician, I see firsthand the critical importance of speed and precision in delivering life-saving treatment.

Combining Medtronic’s proven neurovascular technologies with Brainomix’s AI-driven imaging has the potential to make a real difference: not just in streamlining workflows, but in giving patients a better chance at recovery.”

Key benefits of the partnership include transforming treatment regionally, enhancing diagnostic accuracy, and optimising clinical workflows, helping to alleviate the burden on healthcare providers and increase efficiency across hospital networks.